Yue Wang

PhD, FACMG
Clinical Director, NGS/Molecular

Dr. Yue Wang is a Clinical Director of Next-Generation Sequencing and Molecular Diagnostics at Baylor Genetics. In addition to working at BG, she is an Assistant Professor for the Molecular & Human Genetics department at Baylor College of Medicine.

Dr. Wang received her medical degree from Nanjing Medical College in Nanjing, Jiangsu, China. After receiving her MD, she then pursued her PhD at Mount Sinai School of Medicine in New York, NY, where she also completed her ABMGG fellowship in Clinical Molecular Genetics. 

Dr. Wang continued her research at Mount Sinai School of Medicine as an Assistant Professor investigating genetic risk of holocaust survivors with or without posttraumatic stress disorders (PTSD) using expression microarray, real time PCR, genotyping, and methylation analysis.

Position

Assistant Professor
Molecular and Human Genetics
Baylor College of Medicine
Houston, TX, United States

Clinical Director
NGS/Molecular
Baylor Genetics
Houston, TX, United States

Education

PhD Molecular Medicine from Mount Sinai School of Medicine
New York, NY, United States

MPHil Biomedical Science from Mount Sinai School of Medicine
New York, NY, United States

MD from Nanjing Medical College
Nanjing, Jiangsu, P.R. China

Certifications

Clinical Molecular Genetics
American Board of Medical Genetics

Publications
Clinical and laboratory interpretation of mitochondrial mRNA variants

Lee-Jun C. Wong, Ting Chen, Eric S. Schmitt,  Jing Wang, Sha Tang, Megan Landsverk, Fangyuan Li, Shulin Zhang, Yue Wang, Victor Wei Zhang, William J. Craigen (2020).Clinical and laboratory interpretation of mitochondrial mRNA variants. Hum Mutat  doi: 10.1002/humu.24082. Online ahead of print. PMID: 32652755

Interpretation of mitochondrial tRNA variants

Lee-Jun C. Wong PhD, Ting Chen, MD, Jing Wang, MD, Sha Tang, PhD, Eric S. Schmitt, PhD, Megan Landsverk, PhD, Fangyuan Li, MD, PhD, Yue Wang, PhD, Shulin Zhang, MD, PhD, Victor Wei Zhang, MD, PhD, William J. Craigen, MD, PhD (2020). Interpretation of mitochondrial tRNA variants. Genet Med 22: 917-926 PMID: 31965079

The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN copy-number and sequence variant analysis by massively parallel sequencing

Feng Y, Ge X, Meng L, Scull J, Li J, Tian X, Zhang T, Jin W, Cheng H, Wang X, Tokita M, Liu P, Mei H, Wang Y, Li F, Schmitt ES, Zhang WV, Muzny D, Wen S, Chen Z, Yang Y, Beaudet AL, Liu X, Eng CM, Xia F, Wong LJ, Zhang J. The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN copy-number and sequence variant analysis by massively parallel sequencing. Genetics in Medicine. 2017. PMID: 28125085

Novel LOVD Databases for Hereditary Breast Cancer and Colorectal Cancer genes in the Chinese Population

Pan, M., Cong, P., Wang, Y., Lin, C., Yuan, Y., Dong, J., Banerjee,  S., Zhang, T., Chen, Y., Zhang, T., Chen, M., Hu, P., Zheng, S., Zhang, J., Qi, M. (2011) Novel LOVD Databases for Hereditary Breast Cancer and Colorectal Cancer genes in the Chinese Population.  Hum Mutat. 2011 Dec; 32(12):1335-40. doi:  10.1371/journal.pone.0125571

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Kong, WJ., Wei, J.,  Abidi, P., Lin, MH., Inaba, S., Li, C., Wang, YL., Wang, ZZ.,Si,SY., Pan, HN., Wang, SK., Wu, JD.,Wang, Y., Li, ZR., Liu, JW. and  Jiang, JD. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statinsNat Med. 2004 Dec;10 (12):1344-51. PMID: 15531889

A mouse mammary tumor virus-like LTR superantigen in human breast cancer

Wang, Y.,Jiang, JD., Xu, DP., Li, Y., Qu, CF., Holland, JF. and Pogo, BGT. (2004)  A mouse mammary tumor virus-like LTR superantigen in human breast cancer. Cancer Res. 2004 Jun 15;64(12):4105-11. PMID: 15205319

Yue Wang

PhD, FACMG
Clinical Director, NGS/Molecular

Dr. Yue Wang is a Clinical Director of Next-Generation Sequencing and Molecular Diagnostics at Baylor Genetics. In addition to working at BG, she is an Assistant Professor for the Molecular & Human Genetics department at Baylor College of Medicine.

Dr. Wang received her medical degree from Nanjing Medical College in Nanjing, Jiangsu, China. After receiving her MD, she then pursued her PhD at Mount Sinai School of Medicine in New York, NY, where she also completed her ABMGG fellowship in Clinical Molecular Genetics. 

Dr. Wang continued her research at Mount Sinai School of Medicine as an Assistant Professor investigating genetic risk of holocaust survivors with or without posttraumatic stress disorders (PTSD) using expression microarray, real time PCR, genotyping, and methylation analysis.

Position

Assistant Professor
Molecular and Human Genetics
Baylor College of Medicine
Houston, TX, United States

Clinical Director
NGS/Molecular
Baylor Genetics
Houston, TX, United States

Education

PhD Molecular Medicine from Mount Sinai School of Medicine
New York, NY, United States

MPHil Biomedical Science from Mount Sinai School of Medicine
New York, NY, United States

MD from Nanjing Medical College
Nanjing, Jiangsu, P.R. China

Certifications

Clinical Molecular Genetics
American Board of Medical Genetics

Publications
Clinical and laboratory interpretation of mitochondrial mRNA variants

Lee-Jun C. Wong, Ting Chen, Eric S. Schmitt,  Jing Wang, Sha Tang, Megan Landsverk, Fangyuan Li, Shulin Zhang, Yue Wang, Victor Wei Zhang, William J. Craigen (2020).Clinical and laboratory interpretation of mitochondrial mRNA variants. Hum Mutat  doi: 10.1002/humu.24082. Online ahead of print. PMID: 32652755

Interpretation of mitochondrial tRNA variants

Lee-Jun C. Wong PhD, Ting Chen, MD, Jing Wang, MD, Sha Tang, PhD, Eric S. Schmitt, PhD, Megan Landsverk, PhD, Fangyuan Li, MD, PhD, Yue Wang, PhD, Shulin Zhang, MD, PhD, Victor Wei Zhang, MD, PhD, William J. Craigen, MD, PhD (2020). Interpretation of mitochondrial tRNA variants. Genet Med 22: 917-926 PMID: 31965079

The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN copy-number and sequence variant analysis by massively parallel sequencing

Feng Y, Ge X, Meng L, Scull J, Li J, Tian X, Zhang T, Jin W, Cheng H, Wang X, Tokita M, Liu P, Mei H, Wang Y, Li F, Schmitt ES, Zhang WV, Muzny D, Wen S, Chen Z, Yang Y, Beaudet AL, Liu X, Eng CM, Xia F, Wong LJ, Zhang J. The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN copy-number and sequence variant analysis by massively parallel sequencing. Genetics in Medicine. 2017. PMID: 28125085

Novel LOVD Databases for Hereditary Breast Cancer and Colorectal Cancer genes in the Chinese Population

Pan, M., Cong, P., Wang, Y., Lin, C., Yuan, Y., Dong, J., Banerjee,  S., Zhang, T., Chen, Y., Zhang, T., Chen, M., Hu, P., Zheng, S., Zhang, J., Qi, M. (2011) Novel LOVD Databases for Hereditary Breast Cancer and Colorectal Cancer genes in the Chinese Population.  Hum Mutat. 2011 Dec; 32(12):1335-40. doi:  10.1371/journal.pone.0125571

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Kong, WJ., Wei, J.,  Abidi, P., Lin, MH., Inaba, S., Li, C., Wang, YL., Wang, ZZ.,Si,SY., Pan, HN., Wang, SK., Wu, JD.,Wang, Y., Li, ZR., Liu, JW. and  Jiang, JD. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statinsNat Med. 2004 Dec;10 (12):1344-51. PMID: 15531889

A mouse mammary tumor virus-like LTR superantigen in human breast cancer

Wang, Y.,Jiang, JD., Xu, DP., Li, Y., Qu, CF., Holland, JF. and Pogo, BGT. (2004)  A mouse mammary tumor virus-like LTR superantigen in human breast cancer. Cancer Res. 2004 Jun 15;64(12):4105-11. PMID: 15205319